The American Journal of Medicine
Volume 120, Issue 2, Supplement 1 , Pages S18-S28, February 2007

Endocannabinoid Blockade for Improving Glycemic Control and Lipids in Patients with Type 2 Diabetes Mellitus

  • Priscilla Hollander, MD, PhD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Priscilla Hollander, MD, PhD, Ruth Collins Diabetes Center, Baylor University Medical Center, 696 Wadley Tower, 3600 Baston, Dallas, Texas 75246.

Ruth Collins Diabetes Center, Baylor University Medical Center at Dallas, Dallas, Texas, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0002-9343(06)01363-5

doi:10.1016/j.amjmed.2006.11.014

The American Journal of Medicine
Volume 120, Issue 2, Supplement 1 , Pages S18-S28, February 2007

Article Tools

* Image Usage & Resolution